QUIDELORTHO CORP Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax
QUIDELORTHO CORP (QDEL) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax of -$1.10 million for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax · last filed 2026-08-07
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2025-12-28 was -$900.00K.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2025-09-28 was -$400.00K.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2025-06-29 was $400.00K, a 55.56% decline year-over-year.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2025-03-30 was -$200.00K.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2025 was -$1.10M.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2024 was -$5.00M, a 235.14% decline from fiscal 2023.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2023 was $3.70M, a 3600.00% increase from fiscal 2023.
- QUIDELORTHO CORP other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2023 was $100.00K.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 3 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 12 month |
|---|---|---|---|---|---|
| 2025-12-28 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$1.30M derived: sum of 2 quarters · filed 2026-02-19 | -$900.00K derived: sum of 3 quarters · filed 2026-08-07 | -$1.10M 10-K · filed 2026-02-19 | |
| 2025-09-28 | -$400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2026-08-07 | -$200.00K 10-Q · filed 2025-11-06 | -$1.50M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-29 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $200.00K 10-Q · filed 2026-08-07 | -$1.10M derived: sum of 3 quarters · filed 2026-08-07 | -$12.20M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-30 | -$200.00K 10-Q · filed 2026-05-06 | $200.00K 10-Q · filed 2025-05-08 | -$1.50M derived: sum of 2 quarters · filed 2026-05-06 | -$12.60M derived: sum of 3 quarters · filed 2026-05-06 | -$11.70M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$12.40M derived: sum of 2 quarters · filed 2026-02-19 | -$11.50M derived: sum of 3 quarters · filed 2026-02-19 | -$5.00M 10-K · filed 2026-02-19 | |
| 2024-09-29 | -$11.10M 10-Q · filed 2025-11-06 | -$10.20M derived: sum of 2 quarters · filed 2025-11-06 | -$3.70M 10-Q · filed 2025-11-06 | -$21.00M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-06-30 | $900.00K 10-Q · filed 2025-08-06 | $7.40M 10-Q · filed 2025-08-06 | -$9.90M derived: sum of 3 quarters · filed 2026-02-19 | -$5.30M derived: sum of 4 quarters · filed 2026-02-19 | |
| 2024-03-31 | -$6.50M 10-Q · filed 2025-05-08 | $6.50M 10-Q · filed 2024-05-09 | -$10.80M derived: sum of 2 quarters · filed 2026-02-19 | -$6.20M derived: sum of 3 quarters · filed 2026-02-19 | $3.30M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $300.00K derived: sum of 2 quarters · filed 2026-02-19 | $9.80M derived: sum of 3 quarters · filed 2026-02-19 | $3.70M 10-K · filed 2026-02-19 | |
| 2023-10-01 | $4.60M 10-Q · filed 2024-11-08 | $14.10M derived: sum of 2 quarters · filed 2024-11-08 | $8.00M 10-Q · filed 2024-11-08 | $17.50M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-07-02 | $9.50M 10-Q · filed 2024-08-01 | $3.40M 10-Q · filed 2024-08-01 | $12.90M derived: sum of 3 quarters · filed 2025-02-27 | $14.60M derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-04-02 | $6.10M 10-Q · filed 2024-05-09 | -$6.10M 10-Q · filed 2023-05-04 | $3.40M derived: sum of 2 quarters · filed 2025-02-27 | $5.10M derived: sum of 3 quarters · filed 2025-02-27 | |
| 2023-01-01 | -$2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.00M derived: sum of 2 quarters · filed 2025-02-27 | $100.00K 10-K · filed 2025-02-27 | ||
| 2022-10-02 | $1.70M 10-Q · filed 2023-11-02 | $2.80M 10-Q · filed 2023-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |